Gulf Island Announces Second Quarter 2024 Results Conference Call Date
July 30, 2024 16:05 ET
|
Gulf Island Fabrication, Inc.
THE WOODLANDS, Texas, July 30, 2024 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI), a leading steel fabricator and service provider to the...
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
July 30, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second...
Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024
July 30, 2024 16:05 ET
|
Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics...
Bitcoin Depot Schedules Second Quarter 2024 Conference Call for Tuesday, August 13th at 10:00 am ET
July 30, 2024 16:05 ET
|
Bitcoin Depot Inc.
ATLANTA, July 30, 2024 (GLOBE NEWSWIRE) -- Bitcoin Depot (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, will hold a conference call and...
Inari Medical Reports Second Quarter 2024 Financial Results
July 30, 2024 16:05 ET
|
Inari Medical, Inc.
IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
July 30, 2024 16:05 ET
|
Elutia Inc.
SILVER SPRING, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that it will release its...
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
July 30, 2024 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
July 30, 2024 16:05 ET
|
FibroGen, Inc.
Pamrevlumab arm of the Precision PromiseSM study in metastatic pancreatic cancer, sponsored and conducted by the Pancreatic Cancer Action Network (PanCAN), did not meet the primary endpoint of overall...
Vigil Presents Data on its Small Molecule TREM2 Agonist Program at 2024 Alzheimer's Association International Conference (AAIC)
July 30, 2024 16:05 ET
|
Vigil Neuroscience, Inc.
- First presentation of clinical data on sTREM2 from SAD cohorts in ongoing Phase 1 clinical trial of VG-3927 in healthy volunteers demonstrate proof-of-pharmacology - - New in vitro and in vivo data...
Jet.AI Announces Expiration and Successful Results of Exchange Offer and Consent Solicitation Relating to Warrants
July 30, 2024 16:05 ET
|
Jet.AI. Inc.
LAS VEGAS, July 30, 2024 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence (“AI”) company, announced the...